August 1, 2025 - 19:33

As artificial intelligence continues to reshape various sectors and daily experiences, the University of Wisconsin-Stevens Point is taking significant strides to equip students for a dynamic job market. This fall, the institution is introducing a Bachelor of Science in Artificial Intelligence (AI), designed to merge technical programming skills with a strong emphasis on ethical considerations and real-world applications.
The program aims to address the growing demand for skilled professionals who not only understand the intricacies of AI technology but also recognize the moral implications of its use. By integrating ethics into the curriculum, UW-Stevens Point hopes to foster a generation of graduates who can navigate the complexities of AI responsibly and innovatively.
Students enrolled in this program will engage in hands-on projects and interdisciplinary learning, preparing them to tackle challenges in various fields, from healthcare to finance. As the landscape of technology continues to evolve, this initiative positions UW-Stevens Point at the forefront of AI education, ensuring that its graduates are well-prepared for the future.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...